文献速递妇科产科

超声模型评估卵巢肿瘤的诊断准确性:系统综述与Meta分析

Diagnostic accuracy of ultrasound models for assessment of ovarian tumors: systematic review and meta-analysis.
PubMed 文献 · Ultrasound Obstet Gynecol · 2025-12-04

本系统综述与Meta分析纳入99项研究、共42496个卵巢肿瘤,评估RMI、LR2、SR、ADNEX及主观评估等超声模型鉴别良恶性的准确性。主观评估灵敏度90.2%、特异度91.4%;SR联合主观评估及ADNEX(20%阈值)表现相似;RMI准确性最低。作者结论除RMI外各方法表现良好,ADNEX模型推荐用于不依赖操作者经验的策略。

要点

  • 主观评估灵敏度90.2%、特异度91.4%,但依赖操作者经验。
  • ADNEX模型20%阈值灵敏度86.7%、特异度87.9%,与主观评估无显著差异。
  • RMI准确性最低,RMI版本1(200阈值)灵敏度69.7%、特异度90.5%。

核心结论

  • 除RMI外,所有评估方法均表现良好,可用于鉴别卵巢肿瘤良恶性。
  • 主观评估联合或不联合简单超声规则诊断性能最高,但依赖操作者经验。
  • 若偏好不依赖操作者经验的策略,推荐ADNEX模型;其高灵敏度使漏诊恶性肿瘤的可能性低。
  • 在绝经后女性中,特异度降低可能需采用更高阈值,取决于对假阳性结果影响的评估。

研究设计与样本

  • 系统综述与Meta分析,检索Ovid/MEDLINE、EMBASE和Cochrane Library自建库至2025年6月19日。
  • 纳入99项研究,共描述42496个卵巢肿瘤,其中良性31371个(74%)、恶性11125个(26%)。
  • 纳入标准为前瞻性收集模型参数并提供足够数据构建2×2表的诊断准确性研究。
  • 使用QUADAS-2和QUADAS-C扩展工具评估偏倚风险。

主要发现

  • 主观评估灵敏度90.2%(95%CI 87.8-92.2%),特异度91.4%(95%CI 89.3-93.2%)。
  • 简单超声规则联合对不确定病例行主观评估(SR+SA)灵敏度88.6%(95%CI 85.7-91.0%),P=0.397;特异度91.0%(95%CI 89.0-92.7%),P=0.811,与主观评估相似。
  • ADNEX模型20%阈值灵敏度86.7%(95%CI 80.6-91.0%),P=0.095;特异度87.9%(95%CI 80.1-92.9%),P=0.119,与主观评估相似。
  • ADNEX模型10%阈值灵敏度92.7%(95%CI 90.8-94.2%),P=0.130,与主观评估相似;特异度78.4%(95%CI 71.7-83.8%),P<0.001,低于主观评估。
  • LR2模型10%阈值灵敏度89.5%(95%CI 85.8-92.4%),特异度82.3%(95%CI 75.0-87.8%)。

关键数值与推荐

  • ADNEX模型阈值升高灵敏度下降,阈值降低特异度降低。
  • 亚组分析显示绝经状态和恶性肿瘤患病率均显著影响灵敏度(P<0.01)和特异度(P<0.01)。
  • 绝经后状态和较高疾病患病率与较低特异度相关,绝经前女性灵敏度较低。

临床怎么用

  • 作者结论认为除RMI外所有评估方法均可用于鉴别卵巢肿瘤良恶性。
  • 作者建议若偏好不依赖操作者经验的策略,推荐ADNEX模型。
  • 作者指出绝经后女性中ADNEX模型特异度降低可能需采用更高阈值,取决于对假阳性结果影响的评估。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Accurate preoperative classification of ovarian tumors is essential for guiding treatment. There is an increasing body of data evaluating ultrasound-based models for this purpose in diverse clinical settings. The aim of this systematic review and meta-analysis was to generate up-to-date evidence on the diagnostic accuracy of the most relevant ultrasound-based models, including the Risk of Malignancy Index (RMI) versions 1, 2 and 3, Logistic Regression model 2 (LR2), Simple ultrasound-based Rules (SR), the Assessment of Different NEoplasias in the adneXa (ADNEX) model and subjective assessment (SA), for the differentiation between benign and malignant ovarian tumors. METHODS: Ovid/MEDLINE, EMBASE and the Cochrane Library were searched systematically from database inception until 19 June 2025. Eligible studies investigated the diagnostic accuracy of at least one of the preselected models, collected model parameters prospectively and provided sufficient data to construct 2 × 2 tables. The risk of bias of all included studies was assessed using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS)-2 and QUADAS-C extension tools. Pooled summary estimates of sensitivity and specificity for all included models were calculated and bivariate models were fitted into hierarchical summary receiver-operating-characteristics curves. Bivariate random-effects meta-regression analysis was conducted to determine significant differences in sensitivity and specificity between models. Subgroup analyses were conducted according to menopausal status and prevalence of ovarian malignancy. RESULTS: A total of 99 studies were included, describing 42 496 ovarian tumors, of which 31 371 (74%) were benign and 11 125 (26%) were malignant. SA had both high sensitivity (90.2% (95% CI, 87.8-92.2%)) and high specificity (91.4% (95% CI, 89.3-93.2%)). SR followed by SA of inconclusive cases (SR + SA) showed similar performance to SA (sensitivity, 88.6% (95% CI, 85.7-91.0%); P = 0.397 and specificity, 91.0% (95% CI, 89.0-92.7%); P = 0.811), as did the ADNEX model with a cut-off of 20% (sensitivity, 86.7% (95% CI, 80.6-91.0%); P = 0.095; specificity, 87.9% (95% CI, 80.1-92.9%), P = 0.119). The ADNEX model with a cut-off of 10% had a similar sensitivity to SA (92.7% (95% CI, 90.8-94.2%); P = 0.130), but lower specificity (78.4% (95% CI, 71.7-83.8%); P < 0.001). Higher cut-offs of the ADNEX model led to a decrease in sensitivity, whereas lower cut-offs resulted in reduced specificity. The LR2 model with a 10% cut-off had a sensitivity of 89.5% (95% CI, 85.8-92.4%) and a specificity of 82.3% (95% CI, 75.0-87.8%). The RMI had the lowest diagnostic accuracy, with a sensitivity of 69.7% (95% CI, 67.0-72.2%) and a specificity of 90.5% (95% CI, 88.3-92.4%) for RMI version 1 with a cut-off of 200. Subgroup analyses showed that both menopausal status and prevalence of malignancy significantly affected sensitivity (P < 0.01) and specificity (P < 0.01). Postmenopausal status and higher disease prevalence were associated with lower specificity, while sensitivity was lower in premenopausal women. CONCLUSIONS: All approaches, except for the RMI, performed well and could be used to differentiate between benign and malignant ovarian tumors. Although SA with or without SR had the highest diagnostic performance, it is dependent on operator expertise. If a strategy independent of operator expertise is preferred, the ADNEX model is recommended. Because of the high sensitivity of the ADNEX model, the likelihood of missing malignancies is low. In postmenopausal women, however, the reduced specificity may warrant a higher cut-off, depending on how the impact of a false-positive test result is evaluated. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Lems E, Koch AH, Delvaux EJLG, et al. Diagnostic accuracy of ultrasound models for assessment of ovarian tumors: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2025. PMID: 41346086. doi:10.1002/uog.70135

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。